分子基础和基因测试策略用于诊断21-基酶缺乏症,包括CAH-X综合征
Ja Hye Kim1, Gu-Hwan Kim2, Han-Wook Yoo3
1Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Annals of pediatric endocrinology & metabolism
|July 4, 2023
概括
先天性上腺增生 (CAH) 是由CYP21A2基因突变引起的. 对CAH和CAH-X综合征的基因检测需要评估基因重组和拷贝数变异,以准确诊断和预后.
科学领域:
- 遗传学 遗传学 是一个
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 先天性上腺增生 (CAH) 包含一组影响葡萄糖皮质体和矿物质皮质体合成的自体衰退性疾病.
- 大约95%的CAH病例源于CYP21A2基因的突变,该基因对类固醇21-基酶进行编码.
- CYP21A2基因及其伪基因 (CYP21A1P) 具有很高的序列同质性,导致遗传不稳定性和重组.
研究的目的:
- 审查21-基酶缺乏的分子病理生理学和遗传诊断.
- 突出CAH和连续基因删除综合征,CAH-X综合征的遗传测试策略.
- 强调基因型-表型相关性在指导CAH管理和咨询中的重要性.
主要方法:
- 对CYP21A2突变,基因重组和CAH病理生理学的现有文献的审查.
- 对CAH遗传检测方法的分析,包括桑格测序和副本数变异分析.
- 鉴定的基因型与CAH患者的临床表型和预后的相关性.
主要成果:
- 在CYP21A2和CYP21A1P之间的高序列相似性促进了微转换和重排,使遗传测试复杂化.
- 邻近的TNXB基因中的缺陷,编码着tenascin-X,与CYP21A2突变相结合,导致CAH-X综合征.
- 确定的基因型-表型相关性有助于预测临床结果,并指导CAH和CAH-X综合征的治疗.
结论:
- 准确的CAH遗传诊断需要评估由于CYP21A2 / CYP21A1P同质性的拷贝数变异和基因重组.
- 基因型信息对于早期治疗,预后预测和CAH的遗传咨询至关重要.
- 了解CAH-X综合征的遗传基础对于管理相关的肌肉骨和心脏并发症至关重要.
相关概念视频
Karyotyping
61.9K
Overview
61.9K
Pedigree Analysis
84.5K
Overview
84.5K
Cystic Fibrosis: Pathogenesis
293
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
293
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Inborn Errors of Metabolism
204
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
204


